In 2023, alimentary tract and metabolism medicine sales in Germany stood at approximately $6.86 billion. The forecast for 2024 projects a value of $6.97 billion, indicating a year-on-year increase of approximately 1.6%. The sales are expected to continue growing, reaching $7.42 billion by 2028. This represents an average compound annual growth rate (CAGR) of about 1.95% over the forecasted period from 2024 to 2028.
Future trends to watch for include:
- The impact of an aging population on medication demand.
- Innovations and advancements in drug technology and personalized medicine.
- Regulatory and reimbursement changes within the healthcare system.
- Economic factors influencing healthcare spending and consumer behavior.
